Bellevue Asset Management »

Tetraphase Pharmaceuticals shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Tetraphase Pharmaceuticals shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Tetraphase Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tetraphase Pharmaceuticals held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tetraphase Pharmaceuticals by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2015-12-31 $221k 22k 10.05
2015-09-30 $164k 22k 7.45
2015-06-30 $569k 12k 47.42
2015-03-31 $440k 12k 36.67

More positions owned by Bellevue Asset Management

Celgene Corporation
Biogen Idec (BIIB)
Gilead Sciences (GILD)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Medtronic
Illumina (ILMN)
Abbott Laboratories (ABT)
Mylan
Becton, Dickinson and (BDX)
Cardinal Health (CAH)
UnitedHealth (UNH)
Stryker Corporation (SYK)
Teva Pharmaceutical Industries (TEVA)
Express Scripts Holding

View all positions for Bellevue Asset Management

Top funds holding Tetraphase Pharmaceuticals

Huntington National Bank

View all funds holding Tetraphase Pharmaceuticals